Revenue | ₹602.68Cr |
Net Profits | ₹39.11Cr |
Net Profit Margins | 6.49% |
Epigral Ltd’s revenue fell -7.16% since last year same period to ₹602.68Cr in the Q3 2025-2026. On a quarterly growth basis, Epigral Ltd has generated 2.31% jump in its revenue since last 3-months.
Epigral Ltd’s net profit fell -62.26% since last year same period to ₹39.11Cr in the Q3 2025-2026. On a quarterly growth basis, Epigral Ltd has generated -23.64% fall in its net profits since last 3-months.
Epigral Ltd’s net profit margin fell -59.35% since last year same period to 6.49% in the Q3 2025-2026. On a quarterly growth basis, Epigral Ltd has generated -25.36% fall in its net profit margins since last 3-months.
The revenue for Epigral Ltd in the Q3 results 2025 was ₹602.68Cr.
The net profit for Epigral Ltd in the Q3 results 2025 was ₹39.11Cr.
The net profit margin for Epigral Ltd in the Q3 results 2025 was 6.49%.
The revenue for Epigral Ltd in the Q3 results 2024 was ₹649.19Cr.
The net profit for Epigral Ltd in the Q3 results 2024 was ₹103.63Cr.
The net profit margin for Epigral Ltd in the Q3 results 2024 was 15.96%.